News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Johnson & Johnson (JOBS) Reports Anemia Drug Linked to Deaths in Study
September 18, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TRENTON, N.J. - A blockbuster anemia drug made by a Johnson & Johnson company has been linked to the deaths of some patients in an experiment testing whether it could help stroke patients.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Drug Development
BMS’ Phase 3 win for lung drug clouded by high-dose miss
October 12, 2026
·
4 min read
·
Gabrielle Masson
Cancer
RevMed’s Rasonque gets a subtype data asterisk, but analysts remain bullish
October 12, 2026
·
2 min read
·
Michael Gibney
Radiopharma
BMS’ $4.1B RayzeBio bet delivers Phase 3 radiopharma win
October 12, 2026
·
2 min read
·
Gabrielle Masson
IN PARTNERSHIP WITH ROSE BIOSOLUTIONS
Successful CDMO partnerships hinge on honest—and sometimes critical—support
October 12, 2026
·
5 min read
·
Jennifer C. Smith-Parker